Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases.

chronic liver disease composite hepatic events grip strength muscle mass predictor quality of life

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
20 Apr 2020
Historique:
received: 30 03 2020
revised: 17 04 2020
accepted: 17 04 2020
entrez: 25 4 2020
pubmed: 25 4 2020
medline: 25 4 2020
Statut: epublish

Résumé

Here we sought to clarify the prognostic impact of sarcopenia-related markers (grip strength (GS), muscle mass using bioimpedance analysis and patient quality of life as assessed by the 36-Item Short-Form Health Survey (SF36)) in patients with chronic liver diseases (CLDs, n = 411; 160 liver cirrhosis patients; median age, 64 years) on the incidence of composite hepatic events (CHEs). A GS decrease was defined as <26 kg in men and <18 kg in women, while a skeletal muscle mass index (SMI) decrease was defined as <7.0 kg/m

Identifiants

pubmed: 32325995
pii: diagnostics10040238
doi: 10.3390/diagnostics10040238
pmc: PMC7236004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

Funding: This research received no external funding.

Références

Hepatol Res. 2016 Sep;46(10):951-63
pubmed: 27481650
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
Hepatol Res. 2010 Jan;40(1):8-13
pubmed: 20156296
BMJ. 2010 Sep 09;341:c4467
pubmed: 20829298
Hepatol Res. 2015 Jan;45(2):
pubmed: 25625806
J Hepatol. 2018 Aug;69(2):406-460
pubmed: 29653741
J Clin Med Res. 2018 Dec;10(12):920-927
pubmed: 30425765
Hepatol Res. 2013 Dec;43(12):1264-75
pubmed: 23489325
J Gastroenterol. 2016 Jul;51(7):629-50
pubmed: 27246107
Scand J Gastroenterol. 2015;50(10):1191-8
pubmed: 25876708
J Clin Epidemiol. 1998 Nov;51(11):1045-53
pubmed: 9817122
Lancet. 2014 May 17;383(9930):1749-61
pubmed: 24480518
J Geriatr Phys Ther. 2008;31(1):3-10
pubmed: 18489802
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Nutrition. 2012 May;28(5):495-503
pubmed: 22469110
Hepatology. 2018 Dec;68(6):2405-2412
pubmed: 30070714
Visc Med. 2019 Oct;35(5):282-291
pubmed: 31768391
J Hepatol. 2018 Oct;69(4):793-802
pubmed: 29758335
J Hepatol. 2011 Apr;54(4):650-9
pubmed: 21146892
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):915-925
pubmed: 28627027
Lancet. 2019 Oct 12;394(10206):1335-1343
pubmed: 31492505
Int J Womens Health. 2018 Aug 01;10:397-408
pubmed: 30123008
Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13
pubmed: 16206505
Clin Liver Dis. 2019 Nov;23(4):589-605
pubmed: 31563213
Clin Nutr. 2011 Apr;30(2):135-42
pubmed: 21035927
Hepatol Int. 2017 Jul;11(4):317-370
pubmed: 28620797
Gastroenterology. 2005 Nov;129(5):1464-72
pubmed: 16285948
World J Gastroenterol. 2016 Mar 7;22(9):2844-54
pubmed: 26973423
Clin Gastroenterol Hepatol. 2019 Jul;17(8):1641-1642.e1
pubmed: 30268565
Hepatology. 2017 Mar;65(3):1044-1057
pubmed: 28027577
PLoS One. 2017 Oct 24;12(10):e0186990
pubmed: 29065187
J Hepatol. 2012 Jan;56(1):55-62
pubmed: 21781944
J Hepatol. 2014 Mar;60(3):618-24
pubmed: 24240053
J Clin Med. 2018 Dec 15;7(12):
pubmed: 30558298
Lancet. 2015 Jul 18;386(9990):266-73
pubmed: 25982160
Scand J Med Sci Sports. 2018 Aug;28(8):1852-1858
pubmed: 29723933
Clin Interv Aging. 2018 May 14;13:913-927
pubmed: 29785098
Hepatol Res. 2019 Oct;49(10):1109-1113
pubmed: 31336394
Intervirology. 2008;51 Suppl 1:17-26
pubmed: 18544944
Expert Rev Anti Infect Ther. 2017 Aug;15(8):759-765
pubmed: 28756716
Aliment Pharmacol Ther. 2016 Nov;44(10):1039-1050
pubmed: 27640331
Lancet. 2019 Nov 2;394(10209):1619-1628
pubmed: 31570258
Lancet. 2019 Oct 5;394(10205):1243-1253
pubmed: 31488372
Hepatology. 2018 Jan;67(1):358-380
pubmed: 28130846
Patient Relat Outcome Meas. 2018 Oct 04;9:339-343
pubmed: 30323697
Clin Transl Gastroenterol. 2015 Jul 16;6:e102
pubmed: 26181291
Bone. 2017 Dec;105:276-286
pubmed: 28931495
Aliment Pharmacol Ther. 2020 Jan;51(1):64-77
pubmed: 31701570
Curr Gastroenterol Rep. 2016 Aug;18(8):43
pubmed: 27372291
J Am Geriatr Soc. 2012 Jan;60(1):77-85
pubmed: 22211568
Hum Pathol. 2016 Sep;55:63-71
pubmed: 27189343

Auteurs

Kazunori Yoh (K)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Hiroki Nishikawa (H)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Center for clinical research and education, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Hirayuki Enomoto (H)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Yoshinori Iwata (Y)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Naoto Ikeda (N)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Nobuhiro Aizawa (N)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Takashi Nishimura (T)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Hiroko Iijima (H)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Shuhei Nishiguchi (S)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Classifications MeSH